Transgender and gender diverse individuals face barriers to accessing equitable healthcare. As the liver transplant community works to expand and standardize the living donor evaluation, it is imperative that we consider the unique risk stratification considerations for this marginalized population. Herein, we review the nuances unique to psychosocial and medical considerations, including gender-affirming hormone therapy and perioperative management, with a focus on creating an inclusive environment.
Keywords: gender affirming hormone therapy; living donor liver transplantation; transgender liver donor.
Copyright © 2025 American Association for the Study of Liver Diseases.